1800 519 711 | ltrpharma.com | investors@ltrpharma.com LTR Pharma Limited (ABN 64 644 924 569 / ACN 644 924 569) First ROXUS® Prescriptions Fulfilled in the United States 06 October 2026 Highlights • First patient-specific ROXUS® prescriptions received through Mavrox, Shed’s men’s...
First ROXUS Prescriptions Fulfilled in the United States
Earlier from Ltr Pharma
- SPONTAN Phase II Final Results
- FY26 Results Announcement
- SPONTAN Real-World Study Reports 93% Response
- LTR Executes U.S. Commercial Agreement with Strive
